Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial
OrthoSpineNews
JANUARY 16, 2025
DUBLIN, January 15, 2025–( BUSINESS WIRE )–Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain.
Let's personalize your content